KCK LTD.

Est. AUM

$15.10B

13F long equity, this entity only

Positions

Period

Sep 2025 (Q3)

SEC EDGAR

Sep 2025 (Q3)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	Sight Sciences Inc	COM	$15.05B	4374975	99.66%	SOLE
2	Rein Theraputics Inc	COM NEW	$52.1M	22341	0.34%	SOLE

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.